Pathios Therapeutics
PrivateLast Round
Series B
Apr 18, 2024
Total Funding Raised
$39.4M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Pathios Therapeutics is a biotechnology company that develops small-molecule G protein-coupled receptor (GPR65) inhibitors for applications in immuno-oncology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pathios Therapeutics Comparables
Compare Pathios Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cumulus Oncology | 85% | |
| Grey Wolf Therapeutics | 78% | |
| Arcus Biosciences | 69% | |
Pathios Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Apr 18, 2024 | ||||
| Grant | Sep 27, 2023 | ||||
| Grant | Mar 8, 2021 | ||||
| Series A | Dec 18, 2019 | ||||
| Seed | Feb 6, 2019 |
Key People
Founding team and executive leadership
Pathios Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| UK government | Grant |
| Innovate UK | Grant |
| Canaan Partners | Series B, Series A |
| Brandon Capital | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2026
Monthly visitors grew 1376% MoM, reaching 1.2K.
- Apr 18, 2024
$25M round led by Bristol Myers Squibb.
Pathios Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Pathios Therapeutics's valuation, stock price, and market status.